AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 180 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.50 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $3,578,000 | +32.4% | 58,125 | +28.5% | 0.10% | +27.2% |
Q4 2017 | $2,702,000 | -57.9% | 45,223 | -65.8% | 0.08% | -59.9% |
Q3 2017 | $6,421,000 | +57.6% | 132,118 | +70.4% | 0.20% | +51.9% |
Q2 2017 | $4,075,000 | +55.2% | 77,538 | +33.9% | 0.13% | +62.2% |
Q1 2017 | $2,625,000 | – | 57,890 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LEVIN CAPITAL STRATEGIES, L.P. | 1,373,542 | $15,658,000 | 1.56% |
DAFNA Capital Management LLC | 289,040 | $3,295,000 | 0.87% |
Integral Health Asset Management, LLC | 250,000 | $2,850,000 | 0.82% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 193,266 | $2,203,000 | 0.80% |
PFM Health Sciences, LP | 2,182,684 | $24,883,000 | 0.73% |
DCF Advisers, LLC | 136,501 | $1,556,000 | 0.69% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,977,020 | $33,938,000 | 0.66% |
NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $3,532,000 | 0.61% |
Rhenman & Partners Asset Management AB | 750,000 | $8,550,000 | 0.60% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,232,600 | $14,052,000 | 0.52% |